Ensysce Biosciences Inc Forecast, price target & analysts
Ensysce Biosciences Inc Target price 2025 - Analyst rating & recommendation
Ensysce Biosciences Inc Classifications & Recommendation:
Ensysce Biosciences Inc Price Target
| Target Price | $29.50 |
| Price | $6.29 |
| Potential |
369.00%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Ensysce Biosciences Inc price target 2026.
The average Ensysce Biosciences Inc target price is $29.50.
This is
369.00%
register free of charge
|
|
| A rating was issued by 1 analysts: 1 Analysts recommend Ensysce Biosciences Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ensysce Biosciences Inc stock has an average upside potential 2026 of
369.00%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.23 | 4.15 |
| 11.51% | 86.10% | |
| EBITDA Margin | -480.72% | -173.70% |
| 49.98% | 63.87% |
2 Analysts have issued a sales forecast Ensysce Biosciences Inc 2024 . The average Ensysce Biosciences Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Ensysce Biosciences Inc 2024 . The average Ensysce Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Margin
| 2023 | -480.72% | 49.98% |
|---|---|---|
| 2024 |
-173.70%
63.87%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| EV/Sales | 0.99 |
Based on analysts' sales estimates for 2024, the Ensysce Biosciences Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.93 | 78.85% |
|---|---|---|
| 2024 |
0.99
6.49%
Unlock
|
|
P/S ratio
| Current | 1.86 | 15.74% |
|---|---|---|
| 2024 |
1.98
6.50%
Unlock
|
|
Ensysce Biosciences Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
